NexgenRx, Inc. (NXG.V)
NexgenRx Market Cap : 25.60M for April 1, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Cronos Group, Inc. | 1.350B |
| Medexus Pharmaceuticals, Inc. | 120.63M |
| Arch Biopartners, Inc. | 40.84M |
| Biocure Technology, Inc. | 0.7072M |
| Resverlogix Corp. | 30.17M |
Market Cap Related Metrics
| PE Ratio | 25.71 |
| PS Ratio | 1.523 |
| PEG Ratio | 0.114 |
| Price to Book Value | 4.288 |
| Price | 0.36 |
| Earnings Yield | 3.89% |
| PEGY Ratio | 0.1119 |
| Operating PE Ratio | 14.97 |
| Normalized PE Ratio | 23.08 |